Italia markets open in 2 hours 3 minutes
Dow Jones
38.571,03 -115,27 (-0,30%) Nasdaq
16.828,67 +93,67 (+0,56%) Nikkei 225
38.874,08 -48,92 (-0,13%) EUR/USD
1,0912 +0,0006 (+0,05%) Bitcoin EUR
63.363,47 +569,53 (+0,91%) CMC Crypto 200
1.449,39 -18,55 (-1,26%)
Thorney Technologies Ltd (TTG.F)
Frankfurt - Frankfurt Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
Alla chiusura: 08:10AM CEST
| Chiusura precedente | 0,0715 |
| Aperto | 0,0680 |
| Denaro | 0,0740 x 0 |
| Domanda | 0,0910 x 0 |
| Min-Max giorno | 0,0680 - 0,0680 |
| Intervallo di 52 settimane | 0,0605 - 0,1010 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | 33,406M |
| Beta (mensile su 5 anni) | 1,32 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,0400 |
| Prossima data utili | 27 ago 2024 - 02 set 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireBionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer ADELAIDE, Australia and CAMBRIDGE, Mass., July 03, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced key leadership updates
© 2024 Yahoo. Tutti i diritti riservati.